POLICY CONSIDERATIONS FOR HUMAN MONITORING IN THE WORKPLACE

[1] ASHFORD N, 1984, HARVARD ENV LAW REV, V8

[2] ASHFORD NA, 1977, NOTRE DAME LAWYER, V52, P802

[3] ASHFORD NA, 1986, SEMIN OCCUP MED, V1

[4] CALABRESE E, 1978, METHODOLOGICAL APPRO, P243

[5] DOULL J, 1980, CASARETT DOULLS TOXI, P17

[6] Friedman R, 1981, SENSITIVE POPULATION

[7] HATTIS D, 1981, CPA8117 MIT US DEP L

[8] HATTIS D, 1979, CPAWP799 MED SURV RE

[9] HATTIS D, 1982, CPA8216 US EPA, pCH5

[10] HOLDEN, 1982, SCIENCE, V217, P336

[1] ASHFORD N, 1984, HARVARD ENV LAW REV, V8

[2] ASHFORD NA, 1977, NOTRE DAME LAWYER, V52, P802

[3] ASHFORD NA, 1986, SEMIN OCCUP MED, V1

[4] CALABRESE E, 1978, METHODOLOGICAL APPRO, P243

[5] DOULL J, 1980, CASARETT DOULLS TOXI, P17

[6] Friedman R, 1981, SENSITIVE POPULATION

[7] HATTIS D, 1981, CPA8117 MIT US DEP L

[8] HATTIS D, 1979, CPAWP799 MED SURV RE

[9] HATTIS D, 1982, CPA8216 US EPA, pCH5

[10] HOLDEN, 1982, SCIENCE, V217, P336